Omada Health, Inc. ( (OMDA) ) has released its Q2 earnings. Here is a breakdown of the information Omada Health, Inc. presented to its investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Omada Health, Inc. is a virtual-first healthcare provider specializing in managing chronic conditions such as diabetes, hypertension, and musculoskeletal issues through clinically validated behavior change protocols. The company operates in the digital health sector and is known for its innovative approach to healthcare delivery.
In its second-quarter 2025 earnings report, Omada Health announced a significant 49% increase in revenue, reaching $61 million, alongside a 52% growth in membership. The company highlighted its progress toward profitability and the successful expansion of its GLP-1 companion programs, which are now available through major pharmacy benefit managers in the United States.
Key financial metrics from the report include a gross margin improvement to 66%, up from 60% the previous year, and a reduction in net loss to $5 million from $11 million in the same quarter last year. The company also reported an adjusted EBITDA loss of $0.2 million, a notable improvement from the $6.8 million loss in the previous year. Additionally, Omada Health successfully repaid its outstanding term loan and revolving line of credit, totaling $31.4 million, ahead of schedule.
Looking ahead, Omada Health projects its 2025 revenue to be between $235 million and $241 million, with an adjusted EBITDA loss ranging from $9 million to $5 million. The company’s management remains optimistic about capturing growth opportunities in the cardiometabolic care space and leveraging artificial intelligence advancements to enhance member outcomes.

